Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy: a Prospective, Multicenter, Clinical Trial

NCT06282796 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT06282796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06282796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy: a Prospective, Multicenter, Clinical Trial
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer